Aspira Women's Health Inc. (AWH) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
12117 BEE CAVES ROAD BUILDING THREE AUSTIN, TX 78738 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1,769 | 2,597 | 13,306 | 37,180 | |||||
| Cash and cash equivalent | 1,769 | 2,597 | 13,306 | 37,180 | |||||
| Receivables | 990 | 1,459 | 1,245 | 1,027 | 865 | 924 | |||
| Inventory, net of allowances, customer advances and progress billings | 326 | 227 | 316 | 174 | 30 | 25 | |||
| Inventory | 326 | 227 | 316 | 174 | 30 | 25 | |||
| Prepaid expense | |||||||||
| Other current assets | |||||||||
| Other undisclosed current assets | 1,098 | 997 | 1,442 | 1,624 | 17,708 | 12,461 | |||
| Total current assets: | 4,183 | 5,280 | 16,309 | 40,005 | 18,603 | 13,410 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1,194 | 528 | 282 | 346 | 406 | ||||
| Property, plant and equipment | 69 | 165 | 368 | 464 | 583 | 353 | |||
| Restricted cash and investments | 258 | 251 | 250 | ||||||
| Other noncurrent assets | 45 | 31 | 163 | 14 | 13 | 65 | |||
| Total noncurrent assets: | 1,308 | 982 | 1,064 | 1,074 | 1,002 | 418 | |||
| TOTAL ASSETS: | 5,491 | 6,262 | 17,373 | 41,079 | 19,605 | 13,828 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 4,618 | 4,124 | 4,283 | 6,800 | 4,767 | 3,746 | |||
| Accounts payable | 2,173 | 1,261 | 881 | 1,501 | 1,149 | 1,158 | |||
| Accrued liabilities | 2,445 | 2,863 | 3,402 | 5,299 | 3,618 | 2,588 | |||
| Debt | 843 | 836 | 1,167 | 980 | 1,610 | 193 | |||
| Other liabilities | 39 | ||||||||
| Other undisclosed current liabilities | 7 | 159 | 77 | 60 | 23 | ||||
| Total current liabilities: | 5,468 | 5,119 | 5,527 | 7,840 | 6,400 | 3,978 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1,278 | 1,430 | 2,315 | 3,067 | 3,486 | 1,099 | |||
| Long-term debt, excluding current maturities | 1,278 | 1,430 | 2,315 | 2,718 | 3,077 | 1,099 | |||
| Liabilities, other than long-term debt | 1,248 | 427 | 272 | 13 | |||||
| Other liabilities | 13 | ||||||||
| Operating lease, liability | 1,248 | 427 | 272 | 349 | 409 | ||||
| Other undisclosed noncurrent liabilities | 60 | 1,651 | 2,280 | (349) | (409) | ||||
| Total noncurrent liabilities: | 2,586 | 3,508 | 4,867 | 3,067 | 3,486 | 1,112 | |||
| Total liabilities: | 8,054 | 8,627 | 10,394 | 10,907 | 9,886 | 5,090 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (2,563) | (2,365) | 6,979 | 30,172 | 9,719 | 8,738 | |||
| Common stock | 17 | 11 | 8 | 112 | 105 | 97 | |||
| Additional paid in capital | 528,817 | 515,927 | 508,584 | 501,788 | 449,680 | 430,802 | |||
| Accumulated other comprehensive loss | (531,397) | ||||||||
| Accumulated deficit | (531,397) | (518,303) | (501,613) | (471,728) | (440,066) | (422,161) | |||
| Warrants and rights outstanding | 60 | ||||||||
| Other undisclosed equity, attributable to parent | 531,337 | ||||||||
| Total equity: | (2,563) | (2,365) | 6,979 | 30,172 | 9,719 | 8,738 | |||
| TOTAL LIABILITIES AND EQUITY: | 5,491 | 6,262 | 17,373 | 41,079 | 19,605 | 13,828 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 4,000 | 9,154 | 8,184 | 6,812 | 4,651 | 4,538 | ||
| Other income | 2,000 | |||||||
| Cost of revenue (Cost of Product and Service Sold) | (3,703) | (3,892) | (3,861) | (3,750) | (3,415) | (3,343) | ||
| Other undisclosed gross profit | 5,182 | |||||||
| Gross profit: | 5,479 | 5,262 | 4,323 | 3,062 | 1,236 | 1,195 | ||
| Operating expenses | (21,757) | (24,114) | (35,461) | (35,657) | (19,217) | (16,473) | ||
| Operating loss: | (16,278) | (18,852) | (31,138) | (32,595) | (17,981) | (15,278) | ||
| Nonoperating income (expense) | 3,184 | 2,162 | (468) | 981 | 66 | (18) | ||
| Other nonoperating income (expense) | 1,871 | 485 | (468) | 981 | 66 | (18) | ||
| Interest and debt expense | 1,000 | |||||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 35,820 | |||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (13,094) | (15,690) | (31,606) | (31,614) | 17,905 | (15,296) | ||
| Other undisclosed income from continuing operations before income taxes | 26,188 | 32,390 | 61,491 | 63,276 | ||||
| Income (loss) from continuing operations: | 13,094 | 16,700 | 29,885 | 31,662 | 17,905 | (15,296) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | 31,662 | 17,905 | (15,296) | |
| Net income (loss): | 13,094 | 16,700 | 29,885 | 31,662 | 17,905 | (15,296) | ||
| Other undisclosed net income (loss) attributable to parent | (26,188) | (33,390) | (59,770) | (63,324) | (35,810) | 59 | ||
| Net loss available to common stockholders, diluted: | (13,094) | (16,690) | (29,885) | (31,662) | (17,905) | (15,237) | ||
Comprehensive Income ($ in thousands)
| 3/31/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 13,094 | 16,700 | 29,885 | 31,662 | 17,905 | (15,296) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 13,094 | 16,700 | 29,885 | 31,662 | 17,905 | (15,296) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.